Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs
AKR lymphoma cells derived from spontaneous tumors were serially transplanted at identical inocula. The degree of malignancy and sensitivity to the polysaccharide levan and methotrexate were tested at each transfer by assessing the lag of development of primary and distant tumors and survival of mic...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 1984-05, Vol.44 (5), p.1981-1984 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1984 |
---|---|
container_issue | 5 |
container_start_page | 1981 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 44 |
creator | LEIBOVICI, J |
description | AKR lymphoma cells derived from spontaneous tumors were serially transplanted at identical inocula. The degree of malignancy and sensitivity to the polysaccharide levan and methotrexate were tested at each transfer by assessing the lag of development of primary and distant tumors and survival of mice. A progressive increase in malignancy, accompanied by a loss of sensitivity to levan, were observed following serial passage of the lymphoma. Sensitivity to methotrexate was not affected. It is reasoned that, since serial passages permit a longer exposure of the tumor cells to selective forces of the internal milieu of the organism, better reflecting the situation in a long-life span animal, spontaneous and serial-passage tumors could serve as models for cancer therapy in humans. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_81027775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>81027775</sourcerecordid><originalsourceid>FETCH-LOGICAL-h268t-337f556b30001e7323d912a47ff5395c5abc302ee84b47b49de64e7a410d35063</originalsourceid><addsrcrecordid>eNo9kEtLw0AQxxdRaq1-BGEP4i2w2Ud2c5TiCwoe1HOYJJN0JS93kkO_vVssPc3j_2P4MRdsnRrlEqu1uWRrIYRLjLbymt0Q_cTRpMKs2CqzqVJ5tmbNJwYPHZ-ACFrkY8PnpR8DcT_w3ld4rPMeOc1LfTjHfApjG5DIjwOHoeYz0uyH9gjAEDscpw7iquJ1WFq6ZVcNdIR3p7ph3y_PX9u3ZPfx-r592iV7mbk5Uco2xmSliqYpWiVVnacStG0ao3JTGSgrJSSi06W2pc5rzDRa0KmolRGZ2rDH_7vR73eJTkXvqcKug2i0UOFSIa21JoL3J3Ape6yLKfgewqE4PSbmD6ccqIKuCTBUns6Yc5mUzqo_MOptKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81027775</pqid></control><display><type>article</type><title>Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><source>Highwire Press American Association for Cancer Research - AACR Journals</source><creator>LEIBOVICI, J</creator><creatorcontrib>LEIBOVICI, J</creatorcontrib><description>AKR lymphoma cells derived from spontaneous tumors were serially transplanted at identical inocula. The degree of malignancy and sensitivity to the polysaccharide levan and methotrexate were tested at each transfer by assessing the lag of development of primary and distant tumors and survival of mice. A progressive increase in malignancy, accompanied by a loss of sensitivity to levan, were observed following serial passage of the lymphoma. Sensitivity to methotrexate was not affected. It is reasoned that, since serial passages permit a longer exposure of the tumor cells to selective forces of the internal milieu of the organism, better reflecting the situation in a long-life span animal, spontaneous and serial-passage tumors could serve as models for cancer therapy in humans.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 6713396</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Animals ; Antineoplastic agents ; Biological and medical sciences ; Cell Division - drug effects ; Cell Survival - drug effects ; Drug Evaluation, Preclinical - methods ; Fructans - therapeutic use ; General aspects ; Lymphoma - drug therapy ; Lymphoma - physiopathology ; Male ; Medical sciences ; Methotrexate - therapeutic use ; Mice ; Mice, Inbred AKR ; Neoplasm Transplantation ; Pharmacology. Drug treatments</subject><ispartof>Cancer research (Chicago, Ill.), 1984-05, Vol.44 (5), p.1981-1984</ispartof><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8862287$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6713396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LEIBOVICI, J</creatorcontrib><title>Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>AKR lymphoma cells derived from spontaneous tumors were serially transplanted at identical inocula. The degree of malignancy and sensitivity to the polysaccharide levan and methotrexate were tested at each transfer by assessing the lag of development of primary and distant tumors and survival of mice. A progressive increase in malignancy, accompanied by a loss of sensitivity to levan, were observed following serial passage of the lymphoma. Sensitivity to methotrexate was not affected. It is reasoned that, since serial passages permit a longer exposure of the tumor cells to selective forces of the internal milieu of the organism, better reflecting the situation in a long-life span animal, spontaneous and serial-passage tumors could serve as models for cancer therapy in humans.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Cell Division - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>Fructans - therapeutic use</subject><subject>General aspects</subject><subject>Lymphoma - drug therapy</subject><subject>Lymphoma - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methotrexate - therapeutic use</subject><subject>Mice</subject><subject>Mice, Inbred AKR</subject><subject>Neoplasm Transplantation</subject><subject>Pharmacology. Drug treatments</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLw0AQxxdRaq1-BGEP4i2w2Ud2c5TiCwoe1HOYJJN0JS93kkO_vVssPc3j_2P4MRdsnRrlEqu1uWRrIYRLjLbymt0Q_cTRpMKs2CqzqVJ5tmbNJwYPHZ-ACFrkY8PnpR8DcT_w3ld4rPMeOc1LfTjHfApjG5DIjwOHoeYz0uyH9gjAEDscpw7iquJ1WFq6ZVcNdIR3p7ph3y_PX9u3ZPfx-r592iV7mbk5Uco2xmSliqYpWiVVnacStG0ao3JTGSgrJSSi06W2pc5rzDRa0KmolRGZ2rDH_7vR73eJTkXvqcKug2i0UOFSIa21JoL3J3Ape6yLKfgewqE4PSbmD6ccqIKuCTBUns6Yc5mUzqo_MOptKg</recordid><startdate>19840501</startdate><enddate>19840501</enddate><creator>LEIBOVICI, J</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19840501</creationdate><title>Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs</title><author>LEIBOVICI, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h268t-337f556b30001e7323d912a47ff5395c5abc302ee84b47b49de64e7a410d35063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Cell Division - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>Fructans - therapeutic use</topic><topic>General aspects</topic><topic>Lymphoma - drug therapy</topic><topic>Lymphoma - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methotrexate - therapeutic use</topic><topic>Mice</topic><topic>Mice, Inbred AKR</topic><topic>Neoplasm Transplantation</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LEIBOVICI, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LEIBOVICI, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1984-05-01</date><risdate>1984</risdate><volume>44</volume><issue>5</issue><spage>1981</spage><epage>1984</epage><pages>1981-1984</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>AKR lymphoma cells derived from spontaneous tumors were serially transplanted at identical inocula. The degree of malignancy and sensitivity to the polysaccharide levan and methotrexate were tested at each transfer by assessing the lag of development of primary and distant tumors and survival of mice. A progressive increase in malignancy, accompanied by a loss of sensitivity to levan, were observed following serial passage of the lymphoma. Sensitivity to methotrexate was not affected. It is reasoned that, since serial passages permit a longer exposure of the tumor cells to selective forces of the internal milieu of the organism, better reflecting the situation in a long-life span animal, spontaneous and serial-passage tumors could serve as models for cancer therapy in humans.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>6713396</pmid><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 1984-05, Vol.44 (5), p.1981-1984 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_proquest_miscellaneous_81027775 |
source | MEDLINE; EZB Electronic Journals Library; Highwire Press American Association for Cancer Research - AACR Journals |
subjects | Animals Antineoplastic agents Biological and medical sciences Cell Division - drug effects Cell Survival - drug effects Drug Evaluation, Preclinical - methods Fructans - therapeutic use General aspects Lymphoma - drug therapy Lymphoma - physiopathology Male Medical sciences Methotrexate - therapeutic use Mice Mice, Inbred AKR Neoplasm Transplantation Pharmacology. Drug treatments |
title | Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T17%3A20%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serial%20passage%20of%20tumors%20in%20mice%20in%20the%20study%20of%20tumor%20progression%20and%20testing%20of%20antineoplastic%20drugs&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=LEIBOVICI,%20J&rft.date=1984-05-01&rft.volume=44&rft.issue=5&rft.spage=1981&rft.epage=1984&rft.pages=1981-1984&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E81027775%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81027775&rft_id=info:pmid/6713396&rfr_iscdi=true |